Announcements
- First Quarter 2024: Strong growth in US sales of The NGAL Test
- Resolutions of Annual Geneal Meeting
- Grant of warrants
- BioPorto A/S Appoints Chief Legal Officer
- New Board Candidate for the upcoming Annual Geneal Meeting
- Notice convening the Annual General Meeting in BioPorto A/S
- Correction: BioPorto Announces Annual Results for 2023
- BioPorto appoints Peter Mørch Eriksen as permanent Group Chief Executive Officer
- BioPorto announces preliminary results for 2023 and provides strategic update for the period 2024-2026
- Roche Diagnostics and BioPorto expand collaboration
More ▼
Key statistics
On Thursday, Bioporto A/S (2P4:DEU) closed at 0.236, 81.54% above the 52 week low of 0.13 set on Jun 16, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.233 |
---|---|
High | 0.24 |
Low | 0.219 |
Bid | 0.196 |
Offer | 0.276 |
Previous close | 0.234 |
Average volume | 0.00 |
---|---|
Shares outstanding | 379.67m |
Free float | 338.56m |
P/E (TTM) | -- |
Market cap | 661.39m DKK |
EPS (TTM) | -0.1501 DKK |
Data delayed at least 15 minutes, as of May 23 2024.
More ▼